The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, January 18, 2023
Evaxion Biotech A/S announced that the FDA granted fast-track designation for the Company’s personalized cancer therapy, EVX-01, in combination with ...
read more
The Alzheimer's Association appreciates the Food and Drug Administration's (FDA) methodical process in reviewing treatments for Alzheimer's disease.
read more
Dr. Reddy’s Laboratories Ltd. has successfully completed the full set of clinical studies of its proposed rituximab biosimilar candidate, DRL_RI, for ...
read more
Merck announced that the FDA approved KEYTRUDA, Merck’s anti-PD-1 therapy, as a single agent, for adjuvant treatment following surgical resection and ...
read more
Tuesday, January 31, 2023
Sandoz announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a positive opinion...
read more
Sitero is pleased to announce the addition of Jeff Huntsman to its growing leadership team as Chief Commercial Officer. Jeff brings over 30 years of ...
read more
Eli Lilly and Company announced that the FDA approved an expanded indication for Verzenio® (abemaciclib), in combination with endocrine therapy (ET), ...
read more
Ratio Therapeutics Inc. (Ratio), a pharmaceutical company specializing in the development of targeted radiotherapeutics for the treatment of cancer, ...
read more
Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences industry, with focus on the bio-...
read more
PerkinElmer announced that it has successfully completed the previously announced divestiture of its Applied, Food and Enterprise Services businesses ...
read more
Premier Research announced the addition of Kenneth Ndugga-Kabuye, M.D., FACMG, as VP, Cell & Gene Therapy to the strategic Cell & Gene Therapy (CGT) ...
read more
Biomea Fusion, Inc announced that the FDA cleared the Investigational New Drug (IND) application to begin a Phase I trial (COVALENT-103) of BMF-500, ...
read more
The FDA has approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-...
read more
ANNEXA-I, a post-marketing Phase IV trial to assess the efficacy and safety of Andexxa (andexanet alfa) in patients on oral FXa-inhibitor treatment ...
read more
UPMC announced a collaboration with PharmaLogic Holdings Corp. to facilitate the development of novel radiopharmaceuticals for the diagnosis and ...
read more